IP Library › Granted Patent US 12,303,636
Granted Patent B2
US 12,303,636 · App. 17/241,616 · Granted May 20, 2025

System for gravity inclusion of powder into a medical delivery flow stream

Inventors: John H. Burban (Lake Elmo, MN); John W. Shanahan (White Bear Lake, MN); Michael R. Spearman (The Woodlands, TX); Craig J. Cuta (Stillwater, MN); Keith A. Roberts (Dellwood, MN)
A61M13/00A61M2039/229A61M2202/064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,636
App. No.
17/241,616
Granted
May 20, 2025
Kind
B2
Abstract

A method and apparatus deliver dry, flowable hemostatic powder into a gas flow stream by gravity delivery within a body of the apparatus. The hemostatic powder is then carried with the gas out of the apparatus into an elongated delivery tube inserted into a patient. Delivery of the powder into the gas flow stream creates a bolus of powder and air which becomes more uniformly distributed as it passes through the elongated delivery tube.

Claims (43)

1. A method of delivering dry hemostatic powder to an internal operation site or wound site of mammals, comprising the steps of:

(a) extending a distal end of an elongated tubular delivery channel to a position that an emitting opening of said delivery channel is adjacent to said internal operation site or wound site;

(b) providing a hand-held application device comprising a handle end and a forward end connected to a proximal end of the elongated tubular delivery channel, generating a conveying gas flow containing pressurized gas to mix with dry powder, a receptor for a neutral pressure particulate dry hemostatic powder gravity feeding cartridge, and an internal gas flow path from the handle end to the proximal end and passing under the receptor;

(c) engaging the neutral pressure particulate dry hemostatic powder gravity feeding cartridge onto the receptor;

(d) providing a gas conveying tube connected to the flow path at the handle end of the hand-held application device;

(e) providing gas under pressure to the gas conveying tube to increase gas pressure and cause gas flow through the internal gas flow path and under the receptor;

(f) gravity dropping the dry hemostatic powder from a bottom of the cartridge into the internal gas flow path through the receptor, with pressure within the cartridge having no function in delivering powder into the mixing area;

(g) carrying the dropped dry hemostatic powder in the internal gas flow into the proximal end of the elongated tubular delivery channel; and

(h) delivering the dropped dry hemostatic powder carried in the internal gas flow path to the internal operation site or wound site to assist clotting of blood at the operation site or wound site through the elongated tubular delivery channel.

2. The method of claim 1 wherein the dropped dry hemostatic powder is dropped into the internal gas flow while gas pressure above the dry hemostatic powder in the cartridge is lower than gas pressure within the internal gas flow path.

3. The method of claim 2 wherein the gas pressure in the cartridge is reduced by delivering the dropped dry hemostatic powder into the internal gas flow path creating an increased pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path, and intermittently gas in the internal gas flow path will form a bolus of gas and flow up through the dry hemostatic powder in a bottom section of the cartridge to reduce the pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path, without creating a new gas pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path where the gas pressure in the cartridge never exceeds the gas pressure in the internal gas flow path.

4. The method of claim 1 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below where the gas conveying tube is connected to the flow path as a first bolus of dry hemostatic powder in air separated by volumes of air with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

5. The method of claim 2 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below where the gas conveying tube is connected to the flow path as a first bolus of dry hemostatic powder in air separated by volumes of air with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

6. The method of claim 3 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below where the gas conveying tube is connected to the flow path as a first bolus of dry hemostatic powder in air separated by volumes of air with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

7. The method of claim 1 wherein providing gas under pressure to the gas conveying tube is initiated by a stopcock or valve on the hand-held application device that allows pressure to flow from a gas cylinder or gas pressure line into internal gas flow path in a vector from the handle end to the elongated tubular delivery channel.

8. The method of claim 5 wherein providing gas under pressure to the gas conveying tube is initiated by a stopcock or valve on the hand-held application device that allows pressure to flow from a gas cylinder or gas pressure line into internal gas flow path in a vector from the handle end to the elongated tubular delivery channel.

9. The method of claim 6 wherein providing gas under pressure to the gas conveying tube is initiated by a stopcock or valve on the hand-held application device that allows pressure to flow from a gas cylinder or gas pressure line into internal gas flow path in a vector from the handle end to the elongated tubular delivery channel.

10. The method of claim 9 wherein the first bolus of dry hemostatic powder in air at least partially merges with the volumes of air with a lower concentration of dry hemostatic powder after entering the elongated tubular delivery channel.

11. The method of claim 1 wherein pressure is maintained at approximately equal or less than levels between the cartridge and the internal gas flow path by a gas conductive tube between the cartridge and the internal gas flow path.

12. A method of delivering dry hemostatic powder to an internal operation site or wound site of mammals, comprising the steps of:

(a) extending a distal end of an elongated tubular delivery channel to a position that an emitting opening of said delivery channel is adjacent to said internal operation site or wound site;

(b) providing a hand-held application device comprising a handle end and a forward end connected to a proximal end of the elongated tubular delivery channel, generating a conveying gas flow containing pressurized gas to mix with dry powder, a receptor for a neutral pressure particulate dry hemostatic powder gravity feeding cartridge, and an internal gas flow path from the handle end to the proximal end and passing under the receptor;

(c) engaging the neutral pressure particulate dry hemostatic powder gravity feeding cartridge onto the receptor;

(d) providing a gas conveying tube connected to the flow path at the handle end of the hand-held application device;

(e) providing gas under pressure to the gas conveying tube to increase gas pressure and cause gas flow through the internal gas flow path and under the receptor;

(f) solely gravity dropping the dry hemostatic powder from a bottom of the cartridge into the internal gas flow path through the receptor;

(g) carrying the dropped dry hemostatic powder in the internal gas flow into the proximal end of the elongated tubular delivery channel; and

(h) delivering the dropped dry hemostatic powder carried in the internal gas flow path to the internal operation site or wound site to assist clotting of blood at the operation site or wound site through the elongated tubular delivery channel, wherein the dropped dry hemostatic powder is dropped into the internal gas flow solely by gravity while gas pressure above the dry hemostatic powder in the cartridge is lower than gas pressure within the internal gas flow path, and wherein the gas pressure in the cartridge is reduced by delivering the dropped dry hemostatic powder into the internal gas flow path, the dropped dry hemostatic powder creating an increased pressure differential between gas pressure above the dry hemostatic powder in the cartridge and gas pressure within the internal gas flow path, and intermittently gas in the internal gas flow path will form a bolus of gas and flow up through the dry hemostatic powder in a bottom section of the cartridge to reduce the pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path, without creating a new gas pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path where the gas pressure in the cartridge never exceeds the gas pressure in the internal gas flow path.

13. The method of claim 12 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below the connector as a first bolus of dry hemostatic powder in air separated by volumes of air between at least one subsequent additional bolus of dry hemostatic powder with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

14. The method of claim 12 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below the connector as a first bolus of dry hemostatic powder in air separated by volumes of air with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

15. A method of delivering dry hemostatic powder to an internal operation site or wound site of mammals, comprising the steps of:

(a) extending a distal end of an elongated tubular delivery channel to a position that an emitting opening of said delivery channel is adjacent to said internal operation site or wound site;

(b) providing a hand-held application device comprising a handle end and a forward end connected to a proximal end of the elongated tubular delivery channel, generating a conveying gas flow containing pressurized gas to mix with dry powder, a receptor for a neutral pressure particulate dry hemostatic powder gravity feeding cartridge, and an internal gas flow path from the handle end to the proximal end and passing under the receptor;

(c) engaging the neutral pressure particulate dry hemostatic powder gravity feeding cartridge onto the receptor;

(d) providing a gas conveying tube connected to the flow path at the handle end of the hand-held application device;

(e) providing gas under pressure to the gas conveying tube to increase gas pressure and cause gas flow through the internal gas flow path and under the receptor;

(f) combining the dry hemostatic powder from a bottom of the cartridge into the internal gas flow path through the receptor by force consisting essentially of gravity;

(g) carrying the dropped dry hemostatic powder in the internal gas flow into the proximal end of the elongated tubular delivery channel; and

(h) delivering the dropped dry hemostatic powder carried in the internal gas flow path to the internal operation site or wound site to assist clotting of blood at the operation site or wound site through the elongated tubular delivery channel.

16. The method of claim 15 wherein the dropped dry hemostatic powder is dropped into the internal gas flow while gas pressure above the dry hemostatic powder in the cartridge is lower than gas pressure within the internal gas flow path.

17. The method of claim 16 wherein the gas pressure in the cartridge is reduced by delivering the dropped dry hemostatic powder into the internal gas flow path creating an increased pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path, and intermittently gas in the internal gas flow path will form a bolus of gas and flow up through the dry hemostatic powder in a bottom section of the cartridge to reduce the pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path, without creating a new gas pressure differential between the gas pressure above the dry hemostatic powder in the cartridge and the gas pressure within the internal gas flow path where the gas pressure in the cartridge never exceeds the gas pressure in the internal gas flow path.

18. The method of claim 15 wherein dropped dry hemostatic powder is initially carried in the internal gas flow path at a point below where the gas conveying tube is connected to the flow path as a first bolus of dry hemostatic powder in air separated by volumes of air with a lower concentration of dry hemostatic powder than is present in the first bolus of dry hemostatic powder in air.

19. The method of claim 15 wherein providing gas under pressure to the gas conveying tube is initiated by a stopcock or valve on the hand-held application device that allows pressure to flow from a gas cylinder or gas pressure line into internal gas flow path in a vector from the handle end to the elongated tubular delivery channel.

Continuity (2)
Provisional Application 63014671 · Apr 23, 2020
Related Publication 20210330902A1 · Oct 28, 2021
References Cited (8)
US 10441761B2 · Christakis et al. · 2019 [cited by applicant]
US 11701448B2 · Smith et al. · 2023 [cited by applicant]
US 11931003B2 · Congdon et al. · 2024 [cited by applicant]
US 20110178495A1 · Ji · 2011 [cited by examiner]
US 20110251580A1 · Greenhalgh · 2011 [cited by examiner]
US 20180193574A1 · Smith · 2018 [cited by examiner]
US 20190232030A1 · Pic · 2019 [cited by examiner]
US 20240108402A1 · Govari et al. · 2024 [cited by applicant]